Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer. 1985

S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
September 1987, Cancer treatment reports,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
January 1993, Cancer chemotherapy and pharmacology,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
January 1988, Medical and pediatric oncology,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
May 1991, Investigational new drugs,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
January 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
November 1985, Cancer treatment reports,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
September 1997, Wiener klinische Wochenschrift,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
May 1987, Cancer treatment reports,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
March 1986, Cancer treatment reports,
S Kaplan, and C Sessa, and R Joss, and J P Obrecht, and P Siegenthaler, and F Cavalli
December 2002, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!